Summary
FDA label adherence cannot be verified because no specific FDA-approved aspirin prescribing information was provided, and the evaluated claims are marked as absent/unverifiable from the supplied label evidence.
Category Scores
Accurate Statements
Unsupported Statements
Banana cake itself usually does not have a known interaction with aspirin.
Not supported by the provided label information; no relevant FDA prescribing info section was supplied for food/ingredient-specific interactions.
Aspirin can irritate the stomach and increase bleeding risk.
Claim is marked absent from the label in the provided evaluation data, and no FDA label text/sections were supplied to verify.
Chocolate/cocoa or other acidic components may increase stomach irritation in some people when combined with aspirin.
Food-ingredient-specific interaction guidance is not supported by the provided label information and is marked absent from the label.
High-fat frosting or fillings may slow stomach emptying and worsen indigestion when combined with aspirin.
Mechanistic diet/recipe guidance is not supported by the provided label information and is marked absent from the label.
Alcohol (if used in the recipe) can further irritate the stomach and increase bleeding risk when combined with aspirin.
No label text/sections were supplied to verify alcohol counseling; claim is marked absent from the label.
Taking aspirin with food can reduce irritation compared with taking it on an empty stomach.
No label administration guidance was supplied; claim is marked absent from the label.
More caution is needed when using aspirin due to bleeding risk in people with a history of stomach ulcers or gastrointestinal bleeding.
No contraindications/warnings/precautions text was supplied; claim is marked absent from the label.
More caution is needed when using aspirin due to bleeding risk in people with active gastritis or significant reflux.
No label text/sections were supplied; claim is marked absent from the label (including the specific 'significant reflux' wording).
More caution is needed when using aspirin due to bleeding risk in people using higher-dose aspirin regimens or frequent NSAID use (ibuprofen/naproxen).
No drug interaction/warnings text was supplied; claim is marked absent from the label.
More caution is needed when using aspirin due to bleeding risk in people taking other blood thinners (warfarin, apixaban, rivaroxaban) or antiplatelet drugs.
No drug interaction/warnings text was supplied; claim is marked absent from the label.
Easy bruising after taking aspirin may indicate bleeding and should prompt medical advice.
No adverse reaction/patient counseling text was supplied; claim is marked absent from the label.
Black/tarry stools after taking aspirin may indicate bleeding and should prompt medical advice.
No patient counseling/warnings text was supplied; claim is marked absent from the label.
Vomiting blood after taking aspirin may indicate bleeding and should prompt medical advice.
No patient counseling/warnings text was supplied; claim is marked absent from the label.
Severe stomach pain after taking aspirin may warrant medical advice.
No label-supported criteria for urgency/specific symptoms were supplied; claim is marked absent from the label.
Persistent heartburn after taking aspirin should prompt medical advice.
No label-supported patient counseling criteria were supplied; claim is marked absent from the label.
Contradictions
Important Omissions
No FDA-label-backed details were evaluated for the actual aspirin product’s Contraindications, Boxed Warnings (if any), Warnings & Precautions, Drug Interactions, Adverse Reactions, or specific administration instructions, because no specific label content was provided.
Importance:
High
Safety Assessment
Potential Patient Risk:
Unknown
Claims about GI irritation/bleeding signs and need for medical advice are not verifiable against the provided FDA label evidence; without label text, safety alignment cannot be confirmed.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
No FDA-approved prescribing information (specific product label) was provided, and the evaluated statements are marked as absent/unverifiable from the label context.
Suggested Improvement
Provide the exact FDA-approved aspirin label text/sections (Contraindications, Warnings & Precautions/Boxed Warning if applicable, Drug Interactions, Adverse Reactions, and patient counseling) and align each claim to the cited label wording and scope.